GLESSNER COLEEN (EVP, Quality & Ethics, and CPL) reported 2 transactions at EMERGENT BIOSOLUTIONS INC.
Review the transaction codes below to understand the nature of each event.
Filed: 2/10/2026ACC: 0001919170-26-000003
Officer· EVP, Quality & Ethics, and CPL
Since Mar 2022
-31.70K
Net shares
Net seller
$346.2K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
31.70K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−28.85K
Price / share
$10.92
Trade value
$315.01K
% of position
20.0%
2/6/2026
144.32K→115.47K
Common Stock
Direct
Shares
−2.85K
Price / share
$10.92
Trade value
$31.14K
% of position
2.5%
2/6/2026
115.47K→112.62K
Total
Net shares
−31.70K
Net value
-$346.15K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/6/2026 | D · Disposition | −28.85K | $10.92 | $315.01K | 20.0% | 144.32K | 115.47K |
| Common Stock Direct | 2/6/2026 | F · Tax Withholding | −2.85K | $10.92 | $31.14K | 2.5% | 115.47K | 112.62K |
| Total | −31.70K | -$346.15K | ||||||
Derivative Transactions0
No derivative transactions reported